These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31090629)

  • 21. Limitations of rituximab/IVIg desensitization protocol in kidney transplantation; is this better than a tincture of time?
    Kozlowski T; Andreoni K
    Ann Transplant; 2011; 16(2):19-25. PubMed ID: 21716181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Panel-reactive antibody levels and renal transplantation rates in sensitized patients after desensitization and human leucocyte antigen amino acid residue matching.
    Shang W; Dong L; Feng G; Wang Y; Pang X; Li J; Liu L; Zhang W
    J Int Med Res; 2013 Aug; 41(4):1333-41. PubMed ID: 23780877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody desensitization therapy in highly sensitized lung transplant candidates.
    Snyder LD; Gray AL; Reynolds JM; Arepally GM; Bedoya A; Hartwig MG; Davis RD; Lopes KE; Wegner WE; Chen DF; Palmer SM
    Am J Transplant; 2014 Apr; 14(4):849-56. PubMed ID: 24666831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of the calculated panel-reactive antibody and virtual crossmatch in heart transplantation.
    Chang D; Kobashigawa J
    Curr Opin Organ Transplant; 2012 Aug; 17(4):423-6. PubMed ID: 22790077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteasome inhibition by bortezomib: effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation.
    Guthoff M; Schmid-Horch B; Weisel KC; Häring HU; Königsrainer A; Heyne N
    Transpl Immunol; 2012 Jun; 26(4):171-5. PubMed ID: 22326708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful Heart Transplantation After Desensitization in a Patient With Extremely High Panel-Reactive Antibody Levels and Pretransplant Donor-Specific Antibody: A Case Report.
    Nakamura Y; Yoshioka D; Miyagawa S; Yoshikawa Y; Hata H; Matsuura R; Toda K; Sawa Y
    Transplant Proc; 2018 Dec; 50(10):4067-4070. PubMed ID: 30577317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study.
    De Sousa-Amorim E; Revuelta I; Blasco M; Diekmann F; Cid J; Lozano M; Sánchez-Escuredo A; Martorell J; Palou E; Campistol JM; Oppenheimer F
    Transplant Proc; 2015 Oct; 47(8):2332-5. PubMed ID: 26518919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients.
    Montgomery RA; Lonze BE; Jackson AM
    Curr Opin Organ Transplant; 2011 Aug; 16(4):439-43. PubMed ID: 21666478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates.
    Rostaing L; Congy N; Aarnink A; Maggioni S; Allal A; Sallusto F; Game X; Kamar N
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():201-6. PubMed ID: 25894155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case Report: Successful Living Donor Kidney Transplantation in a Highly Human Leukocyte Antigen-Sensitized Recipient With a Positive Cytotoxic Crossmatch Using Bortezomib-Based Desensitization Without Intravenous Immunoglobulin.
    Revollo JY; Cuffy MC; Abu Jawdeh BG; Paterno F; Girnita A; Brailey P; Alloway RR; Woodle ES
    Transplant Proc; 2015 Sep; 47(7):2254-7. PubMed ID: 26361693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the histocompatibility laboratory in desensitization for transplantation.
    Leffell MS; Zachary AA
    Curr Opin Organ Transplant; 2009 Aug; 14(4):398-402. PubMed ID: 19417655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation.
    Jeong JC; Jambaldorj E; Kwon HY; Kim MG; Im HJ; Jeon HJ; In JW; Han M; Koo TY; Chung J; Song EY; Ahn C; Yang J
    Medicine (Baltimore); 2016 Feb; 95(5):e2635. PubMed ID: 26844479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly Sensitized Patients: Miami Transplant Institute Experience.
    Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
    Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving paradigms for desensitization in managing broadly HLA sensitized transplant candidates.
    Reinsmoen NL; Lai CH; Vo A; Jordan SC
    Discov Med; 2012 Apr; 13(71):267-73. PubMed ID: 22541614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of pre- heart transplantation desensitization in a series of highly sensitized patients bridged with left ventricular assist devices.
    Saadi TA; Lawrecki T; Narang N; Joshi A; Sciamanna C; Pauwaa S; Macaluso G; Tatooles A; Pappas P; Cotts W; Andrade A
    J Heart Lung Transplant; 2021 Oct; 40(10):1107-1111. PubMed ID: 34281777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA antibody profiling in thoracic transplantation undergoing desensitization therapy.
    Zeevi A; Lunz J
    Curr Opin Organ Transplant; 2012 Aug; 17(4):416-22. PubMed ID: 22790076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
    Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates.
    Sriwattanakomen R; Xu Q; Demehin M; Shullo MA; Mangiola M; Hickey GW; Sciortino CM; Horn ET; Keebler ME; Zeevi A
    J Heart Lung Transplant; 2021 Jul; 40(7):595-603. PubMed ID: 33785250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
    Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC
    Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desensitization in the Setting of HLA-Incompatible Kidney Transplant.
    Malvezzi P; Jouve T; Noble J; Rostaing L
    Exp Clin Transplant; 2018 Aug; 16(4):367-375. PubMed ID: 29863455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.